ClinicalTrials.gov record
Recruiting Phase 1 Interventional

FORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a Change in a Gene Called FGFR3

ClinicalTrials.gov ID: NCT05614739

Public ClinicalTrials.gov record NCT05614739. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 22, 2026, 5:13 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

FORAGER-1: A Phase 1, Open-Label, Multicenter Study of LOXO-435 (LY3866288) in Locally Advanced or Metastatic Solid Tumors Including Urothelial Cancer With FGFR3 Alterations

Study identification

NCT ID
NCT05614739
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 1
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
535 participants

Conditions and interventions

Interventions

  • LOXO-435 Drug
  • Pembrolizumab Drug
  • enfortumab vedotin Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 11, 2023
Primary completion
May 31, 2027
Completion
May 31, 2027
Last update posted
Apr 19, 2026

2023 – 2027

United States locations

U.S. sites
42
U.S. states
22
U.S. cities
33
Facility City State ZIP Site status
University of Arizona - Cancer Center Tucson Arizona 85719 Recruiting
City of Hope Duarte California 91010 Recruiting
University of California, Los Angeles (UCLA) - Division of Hematology-Oncology Los Angeles California 90095 Recruiting
University of California - Irvine Orange California 92868 Recruiting
University of California (UC) Davis Comprehensive Cancer Center Sacramento California 95817 Recruiting
Stanford Cancer Center Stanford California 94305 Recruiting
Advent Health Orlando Florida 32804 Recruiting
Emory University Hospital Atlanta Georgia 30322 Recruiting
The University of Chicago Medical Center (UCMC) Chicago Illinois 60637 Recruiting
Indiana University (IU) Melvin and Bren Simon Cancer Center Indianapolis Indiana 46202 Recruiting
Mary Bird Perkins Cancer Center Baton Rouge Louisiana 70809 Recruiting
Ochsner Clinic Foundation New Orleans Louisiana 70121 Recruiting
Johns Hopkins Kimmel Cancer Center Baltimore Maryland 21231-2410 Recruiting
Massachusetts General Hospital Boston Massachusetts 02114 Recruiting
Barbara Ann Karmanos Cancer Institute Detroit Michigan 48201 Recruiting
Washington University in St. Louis St Louis Missouri 63108 Recruiting
New York University (NYU) New York New York 10016 Recruiting
Weill Cornell Medicine New York New York 10021 Not yet recruiting
Icahn School of Medicine at Mount Sinai New York New York 10029 Recruiting
Columbia University New York New York 10032 Recruiting
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center New York New York 10065 Recruiting
University of Rochester - Wilmot Cancer Institute Rochester New York 14642 Recruiting
Montefiore Medical Center The Bronx New York 10467 Recruiting
University of North Carolina (UNC) - Chapel Hill Chapel Hill North Carolina 27599 Recruiting
University of Cincinnati Medical Center (UCMC) Cincinnati Ohio 45267 Recruiting
The Ohio State University (OSU) Columbus Ohio 43210 Recruiting
University of Oklahoma - Health Sciences Center Oklahoma City Oklahoma 73104 Recruiting
Penn Medicine Lancaster General Hospital - Ann B. Barshinger Cancer Institute Lancaster Pennsylvania 17601 Recruiting
University of Pennsylvania Philadelphia Pennsylvania 19104 Recruiting
Thomas Jefferson University Philadelphia Pennsylvania 19107 Recruiting
Allegheny General Hospital Pittsburgh Pennsylvania 15212 Recruiting
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15213 Recruiting
Carolina Urologic Research Center Myrtle Beach South Carolina 29572 Recruiting
Sarah Cannon and HCA Research Institute Nashville Tennessee 37203 Recruiting
Tennessee Oncology Nashville Tennessee 37203 Recruiting
Vanderbilt University Medical Center Nashville Tennessee 37212 Recruiting
University of Texas Southwestern Dallas Texas 75244 Recruiting
Texas Oncology, P.A Dallas Texas 75251 Recruiting
MD Anderson Cancer Center Houston Texas 77030 Recruiting
University of Utah Salt Lake City Utah 84132 Recruiting
University of Vermont Medical Center Burlington Vermont 05401 Recruiting
Inova Schar Cancer Institute Falls Church Virginia 22042 Not yet recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 42 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05614739, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 19, 2026 · Synced Apr 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05614739 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →